drugset / Trial / NCT01525823
Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin
NaSingle-groupOpen-label
Summary
The purpose of this study is to assess the effects of Metformin administered over two weeks on the peak plasma glucose concentrations following administration of BMS-754807.
Timeline
- Start
- 2012-02
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-754807 | Small molecule | 100 mg | Oral |
| Subject | Metformin | Small molecule | 2000 mg | Oral |
Indications
No indication recorded.